Figure 2.

Cardiac consequences of RWPC treatment on cardiac reactivity in response to isoprenaline. Changes in LVDP (a), heart rate (b) and coronary flow (c) in isolated hearts from control rats and those treated with RWPC (20 mg kg⁻¹ day⁻¹), RWPC (20 mg kg⁻¹ day⁻¹)+L-NAME (2 mg kg⁻¹ day⁻¹), or L-NAME (2 mg kg⁻¹ day⁻¹). Columns represent the mean and bars show the s.e.m. of six experiments. ^**P<0.01 shows a significant difference from the control group by two-way ANOVA with repeated measures.